Ravulizumab

Records for this ingredient, by country (identity only).

ATC L04AJ02 · 11 markets · 26 records

Ravulizumab 11 markets · 26 records Forms

Filters

MarketAU 5 US 3 GB 3 CA 2 ES 2 TW 2 HK 2 JP 2 FR 2 SG 1 EU 1

Strength

AU 5 records · 3 shown of 3 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

1,100 mg/11 mLinjectionUltomiris also in GB·ES·JP
+1Other 1 markets
FR
300 mg/3 mLinjectionUltomiris also in GB·ES·JP
+1Other 1 markets
FR
100 mg/mL per mL / per unit basis not statedinjectionULTOMIRIS ravulizumab rch 300 mg in 3 mL (100 mg/mL) concentrated solution for injection by intravenous infusion vial unknown

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Ultomiris 100mg/ml ×1

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

US 3 records · 3 shown of 3 Source openFDA NDC Directory · Data as of 2026-10-23

1,100 mg/11 mLliquidUltomiris
300 mg/3 mLliquidUltomiris
300 mg/30 mLliquidUltomiris

GB 3 records · 3 shown of 3 Source NHSBSA dm+d · Data as of 2026-10-19

1,100 mg/11 mLinjectionUltomiris 300mg/30ml concentrate for solution for infusion vials also in AU·ES·JP
+1Other 1 markets
FR
300 mg/3 mLinjectionUltomiris 300mg/30ml concentrate for solution for infusion vials also in AU·ES·JP
+1Other 1 markets
FR
300 mg/30 mLinjectionUltomiris 300mg/30ml concentrate for solution for infusion vials

CA 2 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

100 mg/1 mLliquidUltomiris

ES 2 records · 2 shown of 2 Source CIMA (AEMPS) · Data as of live

1,100 mg/11 mLinjectionUltomiris also in AU·GB·JP
+1Other 1 markets
FR
300 mg/3 mLinjectionUltomiris also in AU·GB·JP
+1Other 1 markets
FR

TW 2 records · 1 shown of 1 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22

100 mg per mL / per unit basis not statedinjectionUltomiris concentrate for solution for infusion 100mg/ml+2優力適輸注液100毫克/毫升、妥立瑞輸注液100毫克/毫升

HK 2 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

2 records · 0 manufacturers 2 registros · 0 fabricantes 2 个记录 · 0 个厂家 2 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名ULTOMIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 1100MG/11ML ×4

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

JP 2 records · 2 shown of 2 Source 厚生労働省薬価基準収載品目リスト · Data as of 2026-11-01

1,100 mg/11 mLinjectionユルトミリスHI点滴静注1100mg/11mL also in AU·GB·ES
+1Other 1 markets
FR
300 mg/3 mLinjectionユルトミリスHI点滴静注1100mg/11mL also in AU·GB·ES
+1Other 1 markets
FR

FR 2 records · 2 shown of 2 Source Base de données publique des médic · Data as of 2026-11-03

1,100 mg/11 mLinjectionULTOMIRIS 1100 mg/11 mL, solution à diluer pour perfusion also in AU·GB·ES
+1Other 1 markets
JP
300 mg/3 mLinjectionULTOMIRIS 1100 mg/11 mL, solution à diluer pour perfusion also in AU·GB·ES
+1Other 1 markets
JP

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

100 mg/mL per mL / per unit basis not statedinjectionUltomiris concentrate for solution for infusion 100mg/ml

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

1 records · 0 manufacturers 1 registros · 0 fabricantes 1 个记录 · 0 个厂家 1 個記錄 · 0 個廠商

With a brand name Con nombre comercial 有商品名有商品名Ultomiris ×2

Full list in the data package Lista completa en el paquete de datos 完整清单见数据包完整清單見資料包

Some strengths are recorded without a per mL / per unit basis. They are shown as recorded and are not compared with other markets.

Side-by-side table

Strength / form / release	US	GB	CA	AU	SG	ES	TW	HK	JP	EU	FR
1,100 mg/11 mLRecorded as: 1.1 g/11 mL injection	not recorded	Ultomiris 300mg/30ml concentrate for solution for infusion vials	not recorded	Ultomiris	not recorded	Ultomiris	not recorded	not recorded	ユルトミリスHI点滴静注1100mg/11mL	not recorded	ULTOMIRIS 1100 mg/11 mL, solution à diluer pour perfusion
300 mg/3 mL injection	not recorded	Ultomiris 300mg/30ml concentrate for solution for infusion vials	not recorded	Ultomiris	not recorded	Ultomiris	not recorded	not recorded	ユルトミリスHI点滴静注1100mg/11mL	not recorded	ULTOMIRIS 1100 mg/11 mL, solution à diluer pour perfusion
100 mg per mL / per unit basis not stated cannot compare injection	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	Ultomiris concentrate for solution for infusion 100mg/ml 優力適輸注液100毫克/毫升妥立瑞輸注液100毫克/毫升	not recorded	not recorded	not recorded	not recorded
100 mg/mL per mL / per unit basis not stated cannot compare injection	not recorded	not recorded	not recorded	ULTOMIRIS ravulizumab rch 300 mg in 3 mL (100 mg/mL) concentrated solution for injection by intravenous infusion vial	Ultomiris concentrate for solution for infusion 100mg/ml	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
1,100 mg/11 mL liquid	Ultomiris	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
300 mg/3 mL liquid	Ultomiris	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
300 mg/30 mL liquid	Ultomiris	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
100 mg/1 mL liquid	not recorded	not recorded	Ultomiris	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
300 mg/30 mL injection	not recorded	Ultomiris 300mg/30ml concentrate for solution for infusion vials	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded	not recorded
not disclosed unknown	not recorded	not recorded	not recorded	Ultomiris 100mg/ml	not recorded	not recorded	not recorded	ULTOMIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 1100MG/11ML	not recorded	Ultomiris	not recorded

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

2 more strength/form rows are recorded only in CA · TW and are not shown in this table. Hay 2 filas de concentración/forma registradas solo en CA · TW que no se muestran en esta tabla. 另有 2 个规格/剂型仅在 CA · TW 有记录（未在本表显示）。另有 2 個規格/劑型僅在 CA · TW 有記錄（未在本表顯示）。

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Hong Kong records are name/ingredient-level only: no strength, dosage form or registration status; on the register does not prove current supply.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

Ravulizumab

AU 5 records · 3 shown of 3 Source TGA、PBS Schedule API v3 (Department of +1 · Data as of 2026-10-28、live · some records have no stated strength · includes records with unknown status (not proof of sale)

US 3 records · 3 shown of 3 Source openFDA NDC Directory · Data as of 2026-10-23

GB 3 records · 3 shown of 3 Source NHSBSA dm+d · Data as of 2026-10-19

CA 2 records · 1 shown of 1 Source Health Canada Drug Product Databas · Data as of 2026-10-23

ES 2 records · 2 shown of 2 Source CIMA (AEMPS) · Data as of live

TW 2 records · 1 shown of 1 Source 衛生福利部食品藥物管理署（TFDA）全部藥品許可證資料集 · Data as of 2026-10-22

HK 2 records · 0 shown of 0 Source 衞生署藥物辦公室（香港）註冊藥劑製品名單 · Data as of 2026-10-23 · some records have no stated strength · includes records with unknown status (not proof of sale)

JP 2 records · 2 shown of 2 Source 厚生労働省 薬価基準収載品目リスト · Data as of 2026-11-01

FR 2 records · 2 shown of 2 Source Base de données publique des médic · Data as of 2026-11-03

SG 1 records · 1 shown of 1 Source Health Sciences Authority (HSA) · Data as of 2026-08-07

EU 1 records · 0 shown of 0 Source European Commission · Data as of 2026-11-03 · some records have no stated strength

JP 2 records · 2 shown of 2 Source 厚生労働省薬価基準収載品目リスト · Data as of 2026-11-01